Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-Azacytidine Plus Valproic Acid and ATRA in MDS
NCT00439673Phase 2Completed
- Sponsor
- GIMEMA
- Start
- May 2007
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valproic acid, tretinoin in myelodysplastic syndrome (MDS), sponsored by GIMEMA. Started May 2007; status: completed.
02
Drugs
valproic acidtretinoin
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00439673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00439673.